# Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma

> **NCT00514397** · PHASE2 · UNKNOWN · sponsor: **Children's Cancer and Leukaemia Group** · enrollment: 43 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** motexafin gadolinium
- **DRUG:** temozolomide
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00514397
- **Lead sponsor:** Children's Cancer and Leukaemia Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514397, "Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00514397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*